Drug Interactions between Keytruda and Tarceva
This report displays the potential drug interactions for the following 2 drugs:
- Keytruda (pembrolizumab)
- Tarceva (erlotinib)
Interactions between your drugs
No interactions were found between Keytruda and Tarceva. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Keytruda is in the drug class anti-PD-1 monoclonal antibodies.
Keytruda is used to treat the following conditions:
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Hodgkin's Lymphoma
- Melanoma, Metastatic
- Merkel Cell Carcinoma
- Non-Small Cell Lung Cancer
- Primary Mediastinal Large B-cell Lymphoma
- Renal Cell Carcinoma
- Small Cell Lung Cancer
- Solid Tumors
- Urothelial Carcinoma
- Tarceva is in the drug class EGFR inhibitors.
- Tarceva is used to treat the following conditions:
Drug and food interactions
Applies to: Tarceva (erlotinib)
Erlotinib should be taken on an empty stomach 1 hour before or 2 hours after a meal and at the same time each day unless otherwise directed by your doctor. You should also avoid grapefruit and grapefruit juice while taking erlotinib. Food and grapefruit can raise the levels of erlotinib in your body and lead to increased side effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Drug Interaction Classification
|No interaction information available.|